Terms: = Lung cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Prognosis
30 results:
1. Rolapitant treats lung cancer by targeting deubiquitinase OTUD3.
Du T; Gu Q; Zhang Y; Gan Y; Liang R; Yang W; Lu Y; Xu C; Wu J; Ma R; Cao H; Jiang J; Wang J; Feng J
Cell Commun Signal; 2024 Mar; 22(1):195. PubMed ID: 38539203
[TBL] [Abstract] [Full Text] [Related]
2. Primary pulmonary histiocytic sarcoma with high PD-L1 expression benefited from immunotherapy: A case report and bioinformatic analysis.
Lin Y; Cao Q; Hong A; Liang X
Clin Respir J; 2024 Mar; 18(3):e13741. PubMed ID: 38450981
[TBL] [Abstract] [Full Text] [Related]
3. α-Hederin promotes ferroptosis and reverses cisplatin chemoresistance in non-small cell lung cancer.
Han S; Yang X; Zhuang J; Zhou Q; Wang J; Ru L; Niu F; Mao W
Aging (Albany NY); 2024 Jan; 16(2):1298-1317. PubMed ID: 38244586
[TBL] [Abstract] [Full Text] [Related]
4. Nimbolide Exhibits Potent Anticancer Activity Through ROS-Mediated ER Stress and DNA Damage in Human Non-small Cell lung cancer Cells.
Chen X; Zhang H; Pan Y; Zhu N; Zhou L; Chen G; Wang J
Appl Biochem Biotechnol; 2024 Jan; 196(1):182-202. PubMed ID: 37103738
[TBL] [Abstract] [Full Text] [Related]
5. Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma.
Go SI; Park MJ; Park S; Kang MH; Kim HG; Kang JH; Kim JH; Lee GW
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2211-2219. PubMed ID: 34676685
[TBL] [Abstract] [Full Text] [Related]
6. [Role of Palliative Care in the Introduction of Chemotherapy in Patients with Poor Performance Status].
Sato I; Nakaya N; Obara Y; Kurosaka N; Ueno S; Nakajima H
Gan To Kagaku Ryoho; 2021 May; 48(5):735-737. PubMed ID: 34006726
[TBL] [Abstract] [Full Text] [Related]
7. Polyphyllin I promotes cell death via suppressing UPR-mediated chop ubiquitination and degradation in non-small cell lung cancer.
Liu MM; Zhu ML; Dong RF; Zhang C; Zhang H; Yang L; Kong LY; Xia YZ
Chin J Nat Med; 2021 Apr; 19(4):255-266. PubMed ID: 33875166
[TBL] [Abstract] [Full Text] [Related]
8. Expression of the Topoisomerase II Alpha (TOP2A) Gene in lung Adenocarcinoma Cells and the Association with Patient Outcomes.
Du X; Xue Z; Lv J; Wang H
Med Sci Monit; 2020 Dec; 26():e929120. PubMed ID: 33361736
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of molecule GRP94 favors tumor progression in lung adenocarcinoma by interaction with regulatory T cells.
Duan XF; Xin YW
Thorac Cancer; 2020 Mar; 11(3):704-712. PubMed ID: 31970893
[TBL] [Abstract] [Full Text] [Related]
10. miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (chop).
Tan W; Liao Y; Qiu Y; Liu H; Tan D; Wu T; Tang M; Zhang S; Wang H
Cancer Lett; 2018 Aug; 428():55-68. PubMed ID: 29702190
[TBL] [Abstract] [Full Text] [Related]
11. Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.
Wu Y; Zhao L; Chai Y
Niger J Clin Pract; 2018 Mar; 21(3):392-394. PubMed ID: 29519992
[TBL] [Abstract] [Full Text] [Related]
12. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
[TBL] [Abstract] [Full Text] [Related]
13. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
[TBL] [Abstract] [Full Text] [Related]
14. Ezrin Inhibition Up-regulates Stress Response Gene Expression.
Çelik H; Bulut G; Han J; Graham GT; Minas TZ; Conn EJ; Hong SH; Pauly GT; Hayran M; Li X; Özdemirli M; Ayhan A; Rudek MA; Toretsky JA; Üren A
J Biol Chem; 2016 Jun; 291(25):13257-70. PubMed ID: 27137931
[TBL] [Abstract] [Full Text] [Related]
15. Successful Chemo-Radiotherapy for Primary Anaplastic Large Cell Lymphoma of the lung: A Case Report and Literature Review.
Zhao Q; Liu Y; Chen H; Zhang Y; Du Z; Wang J; Wang Y
Am J Case Rep; 2016 Feb; 17():70-5. PubMed ID: 26852792
[TBL] [Abstract] [Full Text] [Related]
16. Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era.
Lu CS; Chen JH; Huang TC; Wu YY; Chang PY; Dai MS; Chen YC; Ho CL
Leuk Lymphoma; 2015 Jul; 56(7):2047-55. PubMed ID: 25382616
[TBL] [Abstract] [Full Text] [Related]
17. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.
Olszewski AJ; Winer ES; Castillo JJ
Leuk Res; 2014 Aug; 38(8):866-73. PubMed ID: 24837081
[TBL] [Abstract] [Full Text] [Related]
18. 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma.
Casulo C; Schöder H; Feeney J; Lim R; Maragulia J; Zelenetz AD; Horwitz S
Leuk Lymphoma; 2013 Oct; 54(10):2163-7. PubMed ID: 23369041
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era.
Takahashi H; Tomita N; Yokoyama M; Tsunoda S; Yano T; Murayama K; Hashimoto C; Tamura K; Sato K; Ishigatsubo Y
Cancer; 2012 Sep; 118(17):4166-72. PubMed ID: 22213346
[TBL] [Abstract] [Full Text] [Related]
20. Cervical extramedullary lymphomatoid granulomatosis.
Montano N; Lucantoni C; Larocca LM; Papacci F; Meglio M
J Clin Neurosci; 2011 Jun; 18(6):851-3. PubMed ID: 21489796
[TBL] [Abstract] [Full Text] [Related]
[Next]